3 terminated, 1 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 3, Completed 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Avigen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury tolperisone HCl (AV650), Placebo - Muscle Spasticity | Phase 2 | Terminated | Avigen | 120 | 2007-09-01 | 2008-11-04 |
| Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis tolperisone HCl - Muscle Spasticity | Phase 2 | Terminated | Avigen | 150 | 2007-09-01 | 2008-11-04 |
| Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain AV411 - Diabetic Neuropathy | Phase 1 / Phase 2 | Completed | Avigen | 36 | 2006-09-01 | 2007-12-19 |
| Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B Adeno-Associated Viral with Human Factor IX - Hemophilia B | Phase 1 / Phase 2 | Terminated | Avigen | 15 | 2004-01-01 | 2007-04-04 |
Muscle Spasticity (2) · Diabetic Neuropathies (1) · Hemophilia B (1) · Multiple Sclerosis (1) · Spinal Cord Injuries (1)
Tolperisone (2) · ibudilast (1)
United States (2) · Australia (1) · Canada (1) · Czechia (1) · Germany (1) · Russia (1) · Serbia (1) · Ukraine (1)
Glenn Morrison, MSc, PhD (1) · Ralph J Marino, MD (1)